Myriad Genetics | MYGN - Stock

Myriad Genetics reported $20.1M in Stock for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Stock Change
Accelerate Diagnostics AXDX:US USD 5.39M 88K
Agilent A:US USD 1.11B 73M
Becton, Dickinson and BDX:US USD 3.6B 380M
Bio Rad Laboratories BIO:US USD 719.32M 33.47M
Biocept BIOC:US 1.9M 352K
Bruker BRKR:US USD 803.7M 54.2M
Danaher DHR:US USD 3.11B 126M
Exact Sciences EXAS:US USD 118.26M 3.56M
Fluidigm FLDM:US USD 21.47M 473K
Hologic HOLX:US USD 677.7M 54M
Illumina ILMN:US USD 568M 9M
Myriad Genetics MYGN:US USD 20.1M 500K
Nanostring Technologies NSTG:US USD 43.27M 2.49M
Orasure Technologies OSUR:US USD 96.23M 17.43M
Pacific Biosciences Of California PACB:US USD 50.38M 6.89M
Perkinelmer PKI:US USD 405.46M 27.21M
Quest Diagnostics DGX:US USD 192M 9M
Quidel QDEL:US USD 524.1M 12.1M
Repligen RGEN:US USD 238.28M 4.42M
Thermo Fisher Scientific TMO:US USD 5.63B 88M
Veracyte VCYT:US USD 14.29M 496K
Waters WAT:US USD 455.71M 13.47M